Aydin Huseynov
Stock Analyst at Ladenburg Thalmann
(0.81)
# 3,695
Out of 4,732 analysts
56
Total ratings
27.45%
Success rate
-25.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Aydin Huseynov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRKR Marker Therapeutics | Maintains: Buy | $11 → $19 | $2.46 | +672.36% | 2 | Oct 21, 2024 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $12 → $21 | $5.01 | +319.16% | 3 | Sep 16, 2024 | |
| CMPX Compass Therapeutics | Upgrades: Buy | $5 | $2.60 | +92.31% | 2 | Sep 16, 2024 | |
| ACRV Acrivon Therapeutics | Upgrades: Buy | $16 | $5.78 | +176.82% | 3 | Sep 16, 2024 | |
| CLDI Calidi Biotherapeutics | Initiates: Buy | $10 | $0.89 | +1,018.69% | 1 | Jun 27, 2024 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $24 → $25 | $13.70 | +82.48% | 2 | May 14, 2024 | |
| SPRB Spruce Biosciences | Downgrades: Neutral | n/a | $0.36 | - | 3 | Mar 14, 2024 | |
| BDRX Biodexa Pharmaceuticals | Initiates: Buy | $200 | $4.28 | +4,572.90% | 1 | Feb 8, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $7 | $1.37 | +410.95% | 1 | Dec 27, 2023 | |
| ZURA Zura Bio | Initiates: Buy | $10 | $1.77 | +464.97% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $9.27 | +547.25% | 1 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $6 | $0.68 | +780.02% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $10 | $3.42 | +192.40% | 3 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $375 → $240 | $1.48 | +16,116.22% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $14 | $0.93 | +1,412.37% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Speculative Buy | $180 → $80 | $0.81 | +9,800.99% | 1 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.33 | +361.89% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.79 | - | 4 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.05 | - | 2 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.59 | +277.36% | 1 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $5.49 | +282.51% | 1 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $0.57 | +52,421.01% | 1 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $5.01 | +638.52% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $20 | $0.89 | +2,142.15% | 3 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $681.58 | - | 6 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $89 | $71.93 | +23.73% | 2 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | n/a | $143.26 | - | 1 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $1,000 | $2.69 | +37,074.72% | 1 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $336 | $2.08 | +16,053.85% | 1 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $5.07 | +255.03% | 1 | Mar 19, 2020 |
Marker Therapeutics
Oct 21, 2024
Maintains: Buy
Price Target: $11 → $19
Current: $2.46
Upside: +672.36%
Corvus Pharmaceuticals
Sep 16, 2024
Maintains: Buy
Price Target: $12 → $21
Current: $5.01
Upside: +319.16%
Compass Therapeutics
Sep 16, 2024
Upgrades: Buy
Price Target: $5
Current: $2.60
Upside: +92.31%
Acrivon Therapeutics
Sep 16, 2024
Upgrades: Buy
Price Target: $16
Current: $5.78
Upside: +176.82%
Calidi Biotherapeutics
Jun 27, 2024
Initiates: Buy
Price Target: $10
Current: $0.89
Upside: +1,018.69%
Capricor Therapeutics
May 14, 2024
Maintains: Buy
Price Target: $24 → $25
Current: $13.70
Upside: +82.48%
Spruce Biosciences
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.36
Upside: -
Biodexa Pharmaceuticals
Feb 8, 2024
Initiates: Buy
Price Target: $200
Current: $4.28
Upside: +4,572.90%
PMV Pharmaceuticals
Dec 27, 2023
Initiates: Buy
Price Target: $7
Current: $1.37
Upside: +410.95%
Zura Bio
Oct 10, 2023
Initiates: Buy
Price Target: $10
Current: $1.77
Upside: +464.97%
Sep 22, 2023
Initiates: Buy
Price Target: $60
Current: $9.27
Upside: +547.25%
Aug 14, 2023
Maintains: Buy
Price Target: $10 → $6
Current: $0.68
Upside: +780.02%
Jun 5, 2023
Maintains: Buy
Price Target: $20 → $10
Current: $3.42
Upside: +192.40%
May 16, 2023
Maintains: Buy
Price Target: $375 → $240
Current: $1.48
Upside: +16,116.22%
Apr 28, 2023
Maintains: Buy
Price Target: $8 → $14
Current: $0.93
Upside: +1,412.37%
Apr 4, 2023
Maintains: Speculative Buy
Price Target: $180 → $80
Current: $0.81
Upside: +9,800.99%
Mar 7, 2023
Initiates: Buy
Price Target: $20
Current: $4.33
Upside: +361.89%
Nov 4, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.79
Upside: -
Aug 23, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.05
Upside: -
Jul 27, 2022
Initiates: Buy
Price Target: $6
Current: $1.59
Upside: +277.36%
Jul 13, 2022
Initiates: Buy
Price Target: $21
Current: $5.49
Upside: +282.51%
May 6, 2022
Initiates: Buy
Price Target: $300
Current: $0.57
Upside: +52,421.01%
May 2, 2022
Initiates: Buy
Price Target: $37
Current: $5.01
Upside: +638.52%
Nov 8, 2021
Upgrades: Buy
Price Target: $20
Current: $0.89
Upside: +2,142.15%
Nov 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $681.58
Upside: -
Jul 20, 2021
Upgrades: Buy
Price Target: $89
Current: $71.93
Upside: +23.73%
Sep 30, 2020
Initiates: Hold
Price Target: n/a
Current: $143.26
Upside: -
Jun 16, 2020
Initiates: Speculative Buy
Price Target: $1,000
Current: $2.69
Upside: +37,074.72%
May 21, 2020
Initiates: Buy
Price Target: $336
Current: $2.08
Upside: +16,053.85%
Mar 19, 2020
Initiates: Buy
Price Target: $18
Current: $5.07
Upside: +255.03%